Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study-Reference-Cited by-同舟云学术

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Published:2021-09 Issue:9 Volume:16 Page:1570-1581
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Johnson Melissa L.,Zvirbule Zanete,Laktionov Konstantin,Helland Aslaug,Cho Byoung Chul,Gutierrez Vanesa,Colinet Benoît,Lena Herve,Wolf Martin,Gottfried Maya,Okamoto Isamu,van der Leest Cor,Rich Patricia,Hung Jen-Yu,Appenzeller Christina,Sun Zhaowen,Maag David,Luo Yan,Nickner Caroline,Vajikova Alena,Komarnitsky Philip,Bar Jair

Funder

AbbVie Inc

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects;Demedts;Eur Respir J,2010

2. Treatment options for relapsed small-cell lung cancer: what progress have we made?;Qin;J Oncol Pract,2018

3. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018

4. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019

5. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis;Bulman;Nat Genet,2000

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies;Cancers;2024-09-06

2. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

3. Aktuelle Standards und vielversprechende Innovationen in der medikamentösen Zweitlinientherapie des metastasierten kleinzelligen Lungenkarzinoms (ED-SCLC);Die Onkologie;2024-08-02

4. Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research;Discover Oncology;2024-08-01

5. Rediscovering immunohistochemistry in lung cancer;Critical Reviews in Oncology/Hematology;2024-08